Tuncel, A., Maschauer, S., Prante, O. & Yurt, F. (2024.0) In Vitro Assessment of <SUP>177</SUP>Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer. PHARMACEUTICALS , 17.0(6.0), 21.0.